Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports.
According to Zacks, “Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic institutions to deepen the understanding of real-time human biology. It operates principally in Europe, North America and Asia. Olink Holding AB is headquartered in Uppsala, Sweden. “
OLK has been the subject of several other research reports. The Goldman Sachs Group dropped their price target on shares of Olink Holding AB (publ) from $34.00 to $20.00 and set a “neutral” rating for the company in a research note on Wednesday, April 13th. Morgan Stanley lowered their target price on shares of Olink Holding AB (publ) from $33.00 to $32.00 and set an “equal weight” rating for the company in a research note on Monday, February 14th. Finally, BTIG Research decreased their price target on shares of Olink Holding AB (publ) from $44.00 to $37.00 in a research note on Wednesday, February 16th.
Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) last announced its earnings results on Monday, February 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.02 by ($0.09). The business had revenue of $43.68 million for the quarter, compared to analyst estimates of $43.50 million. Olink Holding AB (publ) had a negative return on equity of 7.68% and a negative net margin of 40.37%. As a group, equities analysts forecast that Olink Holding AB will post -0.41 EPS for the current year.
Hedge funds and other institutional investors have recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of Olink Holding AB (publ) during the fourth quarter valued at about $178,000. Raymond James & Associates grew its holdings in shares of Olink Holding AB (publ) by 5.9% during the third quarter. Raymond James & Associates now owns 8,796 shares of the company’s stock valued at $213,000 after buying an additional 487 shares during the last quarter. Jump Financial LLC acquired a new position in shares of Olink Holding AB (publ) during the third quarter valued at about $226,000. Marshall Wace LLP purchased a new position in Olink Holding AB (publ) during the third quarter worth about $287,000. Finally, Geode Capital Management LLC boosted its holdings in Olink Holding AB (publ) by 75.1% during the fourth quarter. Geode Capital Management LLC now owns 19,562 shares of the company’s stock worth $356,000 after purchasing an additional 8,387 shares during the last quarter. Hedge funds and other institutional investors own 26.67% of the company’s stock.
About Olink Holding AB (publ) (Get Rating)
Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line that consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on.
- Get a free copy of the StockNews.com research report on Olink Holding AB (publ) (OLK)
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Olink Holding AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olink Holding AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.